Hybrid BioSystems Company
Hybrid BioSystems develops gene therapy treatments for ovarian and prostate cancer. It exploits the interface between polymer chemistry.
Industry:
Women Cancer Treatment
Technology:
Cancer
Funding Status:
M&A
Headquarters:
Upper Heyford, Somerset, United Kingdom